Comment: This highly recommended pharma practice supporting pharma advertising expert von Czettritz is consistently present in the market representing its loyal client base in pharma advertising proceedings. Proceedings against the Federal Institute for Drugs and Medical Devices also bear huge significance for the practice. Against the backdrop of the anticorruption law, the team is reviewing contracts for its regular clients. Although the firm once again had to overcome internal losses from its ?patent team, this had no impact on the autonomous pharma practice.
Strengths: Pharma advertising and patent proceedings.
Recommended: Peter von Czettritz (“good industry insider”, competitor).
Practice: Primarily advice to pharma and medical product manufacturers from authorization onwards. Also pharma advertising, retroactive authorization and demarcation from food. Strong ?patent practice. Also reimbursement issues, antitrust, ?trademarks and unfair competition and compliance. Clients: originators, generic drug manufacturers and parallel importers. (Core team: 1 partner, 2 associates)
Clients: ?? Public knowledge: pharma law for Novartis; pharmaceutical company against Wettbewerbszentrale on advertising; various pharmaceutical companies on advertising; various pharmaceutical companies on anticorruption law; various pharmaceutical companies on third-party opposition against Federal Institute for Drugs and Medical Devices; pharmacist against health insurer concerning demands for information according to the Freedom of Information Act in connection with discount agreements.
  • Teilen